Evaluation of the berberis vulgaris effects against leishmaniasis

Phase 1

Recruiting

• Conditions: Cutaneous leishmaniasis.; Cutaneous leishmaniasis; B55.1

• Registration Number: IRCT20240510061730N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

positive leishmaniosis disease (except face)
not pregnant
ages: 20-70 y
not other diseases
normal kidney and liver tests

Exclusion Criteria

Facial lesions
pregnancy and lactation
Immunosuppressive medications

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
esion size. Timepoint: Measurement of lesion size before starting treatment, every week during treatment (0 to 8). Method of measurement: Complete recovery: 100% healing of the wound and its secretions, Significant healing: healing between 76 and 99 percent, Partial healing: healing between 51 and 75%, Partial recovery: recovery between 26 and 50%, Non-healing: reducing the size of the wound to less than 26%, Treatment failure: no change in wound size or discharge.